Title:
LACTOBACILLUS-CONTAINING AGENT FOR REDUCING AMMONIA IN BLOOD
Document Type and Number:
Japanese Patent JP2009102324
Kind Code:
A
Abstract:
To provide a preparation for effectively utilizing lactobacillus or bifidobacteria not only for intestinal disorder-controlling action but also for amelioration of various kinds of symptoms of other diseases.
The concentration of ammonia in the blood can be reduced by ingesting the lactobacillusor the bifidobacteria of not less than a specified quantity by using an enteric preparation containing the live lactobacillus or bifidobacteria.
More Like This:
Inventors:
NIWA TOSHIMITSU
TAKAYAMA FUMIO
TOMONO KIYOSHI
GOTO TSUNEO
TAKI KENTARO
TAKAYAMA FUMIO
TOMONO KIYOSHI
GOTO TSUNEO
TAKI KENTARO
Application Number:
JP2008302747A
Publication Date:
May 14, 2009
Filing Date:
November 27, 2008
Export Citation:
Assignee:
MORISHITA JINTAN CO
INST NAGOYA IND SCIENCE RES
INST NAGOYA IND SCIENCE RES
International Classes:
A61K35/74; A61K9/48; A61K35/744; A61K35/745; A61P3/12
Domestic Patent References:
JPH04166079A | 1992-06-11 | |||
JPH10286078A | 1998-10-27 | |||
JPH07298833A | 1995-11-14 | |||
JPH0656680A | 1994-03-01 | |||
JPH08242763A | 1996-09-24 | |||
JPH11199495A | 1999-07-27 | |||
JPH11199494A | 1999-07-27 | |||
JPH11139978A | 1999-05-25 |
Foreign References:
WO2002058712A2 | 2002-08-01 | |||
WO2003001927A1 | 2003-01-09 |
Attorney, Agent or Firm:
Hiromichi Nanjo
Previous Patent: LACTOBACILLUS-CONTAINING AGENT FOR REDUCING HOMOCYSTEINE IN BLOOD
Next Patent: AZETIDINE DERIVATIVE AS CCR-3 RECEPTOR ANTAGONIST
Next Patent: AZETIDINE DERIVATIVE AS CCR-3 RECEPTOR ANTAGONIST